ESMO 2022

Lymphoma-Specific Questionnaire Addresses Unmet Patient Needs

Researchers developed an instrument to identify unmet needs and quality-of-life outcomes for patients with lymphoma.

PLM60 Plus Pegaspargase Shows Promise in Extranodal Natural Killer and T-Cell Lymphoma

Researchers sought to determine whether PLM60 with pegaspargase would have efficacy in patients with extranodal natural killer/T-cell lymphoma.

Orelabrutinib Plus RCHOP Effective for Extranodal, Non-GCB Diffuse Large B-Cell Lymphoma

The aim of this trial was to evaluate the efficacy and safety of orelabrutinib with RCHOP in patients with extranodal non-GCB DLBCL.

Long-Acting G-CSF May Reduce FN-Related Hospitalization in DLBCL After R-CHOP

Long-acting G-CSF can reduce the risk of hospitalization related to febrile neutropenia in patients with DLBCL treated with R-CHOP.

Treatment Advances Have Improved Multiple Myeloma Mortality in the US

Researchers sought to determine the mortality trends for patients with multiple myeloma over the past few decades.